See more : LIGATT Security International, Inc. (LGTT) Income Statement Analysis – Financial Results
Complete financial analysis of Scienture Holdings, Inc. (SCNX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Scienture Holdings, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Cayson Acquisition Corp Ordinary shares (CAPN) Income Statement Analysis – Financial Results
- Fujian Fynex Textile Science & Technology Co., Ltd. (600493.SS) Income Statement Analysis – Financial Results
- Monument Circle Acquisition Corporation (MONCW) Income Statement Analysis – Financial Results
- RF Capital Group Inc. (GMPXF) Income Statement Analysis – Financial Results
- DFM Foods Limited (DFMFOODS.NS) Income Statement Analysis – Financial Results
Scienture Holdings, Inc. (SCNX)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.trxadehealth.com
About Scienture Holdings, Inc.
TRxADE HEALTH, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics and independent pharmacies. TRxADE HEALTH, Inc. is headquartered in Tampa, Florida.
Scienture, LLC, a wholly owned subsidiary of Scienture Holdings, Inc. (NASDAQ: SCNX) Announces Issuance of a New Patent Covering its first product SCN-102 (Losartan Potassium Oral Suspension, 10mg/mL) through 2041
Source: https://incomestatements.info
Category: Stock Reports